Secondary Hypertension: Novel Insights

Author(s): Konstantinos Tziomalos*

Journal Name: Current Hypertension Reviews

Volume 16 , Issue 1 , 2020


Become EABM
Become Reviewer
Call for Editor

Abstract:

It is estimated that 5-10% of hypertensive patients have secondary hypertension. The main causes of secondary hypertension are parenchymal renal disease, primary aldosteronism and renovascular hypertension. The identification of these patients is important because it enables the etiological management of the underlying disease and in some cases leads to blood pressure control without antihypertensive medications. On the other hand, diagnostic evaluation for secondary hypertension often includes complex and expensive tests and should be performed only in patients with a strong clinical suspicion for its presence. If preliminary screening tests suggest the presence of secondary hypertension, these patients should be referred to specialized centers for further diagnostic evaluation and comprehensive management.

Keywords: Secondary hypertension, primary aldosteronism, chronic kidney disease, renovascular hypertension, pheochromocytoma, disease.

[1]
Sinclair AM, Isles CG, Brown I, Cameron H, Murray GD, Robertson JW. Secondary hypertension in a blood pressure clinic. Arch Intern Med 1987; 147: 1289-93.
[2]
Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 2004; 27: 193-202.
[3]
Anagnostis P, Karagiannis A, Tziomalos K, Athyros VG, Kita M, Mikhailidis DP. Endocrine hypertension: Diagnosis and management of a complex clinical entity. Curr Vasc Pharmacol 2010; 8: 646-60.
[4]
Katsimardou A, Imprialos K, Stavropoulos K, Sachinidis A, Doumas M, Athyros V. Hypertension in metabolic syndrome: Novel insights. Curr Hypertens Rev 2020; 16(1): 12-8.
[5]
Stavropoulos K, Imprialos K, Papademetriou V, et al. Primary aldosteronism: Novel insights. Curr Hypertens Rev 2020; 16(1): 19-23.
[6]
Boutari C, Georgianou E, Sachinidis A, et al. Renovascular hypertension: Novel insights. Curr Hypertens Rev 2020; 16(1): 24-9.
[7]
Natsis M, Antza C, Doundoulakis I, Stabouli S, Kotsis V. Hypertension in obesity: Novel insights. Curr Hypertens Rev 2020; 16(1): 30-6.
[8]
Chrysaidou K, Chainoglou A, Karava V, Dotis J, Printza N, Stabouli S. Secondary hypertension in children and adolescents: Novel insights. Curr Hypertens Rev 2020; 16(1): 37-44.
[9]
Duni A, Dounousi E, Pavlakou P, Eleftheriadis T, Liakopoulos V. Hypertension in chronic kidney disease: Novel insights. Curr Hypertens Rev 2020; 16(1): 45-54.
[10]
Macut D, Mladenović V, Bjekić-Macut J, et al. Hypertension in polycystic ovary syndrome: novel insights. Curr Hypertens Rev 2020; 16(1): 55-44.
[11]
G. Lamirault, M. Artifoni, M. Daniel, N. Barber-Chamoux. Resistant Hypertension: Novel Insights. Curr Hypertens Rev 2020; 16(1): 61-72.


open access plus

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 16
ISSUE: 1
Year: 2020
Published on: 13 February, 2020
Page: [11 - 11]
Pages: 1
DOI: 10.2174/1573402115666190416161116

Article Metrics

PDF: 35
HTML: 8